False-positive xerostomia following radioactive iodine treatment: case report

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 103, Issue 2, 2007, Pages

  Mandel, Susan J ^a   Mandel, Louis ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Columbia University College of Dental Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DIAGNOSTIC AGENT; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; TRAZODONE;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; LABORATORY DIAGNOSIS; MALE; PAROTID GLAND; RADIATION EXPOSURE; SIALOADENITIS; THYROID TUMOR; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; HUMANS; IODINE RADIOISOTOPES; MALE; PAROTID GLAND; RADIOPHARMACEUTICALS; SIALADENITIS; SODIUM PERTECHNETATE TC 99M; THYROID NEOPLASMS; TRAZODONE; XEROSTOMIA;

EID: 33846258800     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2006.08.004     Document Type: Article

References (28)

1. Mazzaferri E. Carcinoma of the follicular epithelium. In: Braverman L.E., and Utiger R.D. (Eds). Werner and Ingbar's the thyroid (2000), Lippincott, Philadelphia (PA) 904-929
2. Blahd W.H. Treatment of malignant thyroid disease. Semin Nucl Med 9 (1979) 95-99
3. In: DeGroot I.J., Larsen P.R., and Hennemann G. (Eds). The thyroid and its diseases. 6th ed (1996), Churchill Livingstone, New York 658-696
4. Freitas J.E., Gross M.D., Ripley S., and Shapiro B. Radionuclide diagnosis and therapy of thyroid cancer: current status report. Semin Nucl Med 15 (1985) 106-131
5. Mandel S.J., and Mandel L. Persistent sialadenitis after radioactive iodine therapy: report of two cases. J Oral Maxillofac Surg 57 (1999) 738-741
6. Mandel S.J., and Mandel L. Review: radioactive iodine and the salivary glands. Thyroid 13 (2003) 265-271
7. Myant N.B. Iodine metabolism of salivary glands. Ann N Y Acad Sci 85 (1960) 208-214
8. DiRusso G., and Kern K.A. Comparative analysis of complications from 1-131 radioablation for well-differentiated thyroid cancer. Surgery 116 (1994) 1024-1030
9. Levenson D., Goulec S., Sonenberg M., Lai E., Goldsmith S.J., and Larson S.M. Peripheral facial nerve palsy after high-dose radioiodine therapy in patients with papillary thyroid carcinoma. Ann Int Med 120 (1994) 576-578
10. Gates G.A., and Work W.P. Radioisotope scanning of the salivary glands. Laryngoscope 77 (1967) 861-875
11. Mishkin F.S. Radionuclide salivary gland imaging. Semin Nucl Med 11 (1981) 258-265
12. Newkirk K.A., Ringel M.D., Wartofsky L., and Burman K.D. The role of radioactive iodine in salivary gland dysfunction. Ear Nose Throat J 79 (2000) 460-468
13. McCall M.S., Timm L., and Frenkel E.P. Chewing tobacco and radioiodine. [letter]. Lancet 1 (1967) 902
14. Rigler R.G., and Scanlon P.W. Radiation parotitis from radioactive iodine therapy. Proc Staff Meet Mayo Clin 149 (1955) 30-35
15. Abramsom A.L., Levy L.M., Goodman M., and Attie J.N. Salivary gland scinti-scanning with technetium 99m pertechnetate. Laryngoscope 79 (1969) 1105-1117
16. Abok K., Brunk U., Jung B., and Ericsson J. Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland. Virchows Arch B Cell Pathol 45 (1984) 443-460
17. Bohuslavizki K.H., Brenner W., Klutmann S., Hubner R.-H., Lassmann S., Feyerabend B., et al. Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy. J Nucl Med 39 (1998) 1237-1242
18. Nagler R., Marmary Y., Golan E., and Chevion M. Novel protection strategy against x-ray-induced damage to salivary glands. Radiat Res 149 (1998) 271-276
19. Schneyer L.H. Effect of administration of radioactive iodine in human salivary gland function. J Dent Res 32 (1953) 146
20. Hilton G., Pochin E.E., Cunningham R.M., and Halnan K.E. The role of radioiodine in the treatment of carcinoma of the thyroid. Br J Radiol 29 (1956) 297-310
21. Goolden A.W.G., Malland J.R., and Farran H.E.A. Radiation sialitis following radioiodine therapy. Br J Radiol 30 (1957) 210-212
22. Van Nostarnd D., Neutze J., and Atkins F. Side effects of "rational close" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med 27 (1986) 1519-1527
23. Allweiss P., Braunstein G.D., Katz A., and Wayman A. Sialadentis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med 25 (1984) 755-758
24. Weisenfeld D., Webster G., Cameron F., Ferguson M.M., McFadyen E.E., and McFarlane T.W. Salivary gland dysfunction following radioactive iodine therapy. Oral Surg Oral Med Oral Pathol 55 (1983) 138-141
25. Laupa M.S., Toth B.B., Keene H.J., and Sellin R.V. Effects of radioactive iodine therapy on salivary flow rates and oral streptococcus mutans prevalence in patients with thyroid cancer. Oral Surg Oral Med Oral Pathol 75 (1993) 312-317
26. Spiegel W., Reiners C., and Borner W. Sialadenitis following iodine-131 therapy for thyroid carcinoma. [letter]. J Nucl Med 26 (1985) 816
27. Albrecht H.H., and Creutzig H. Funktions zintigraphie der Speicheldrusen nach hochdorsierter Radiojodtherapie. Rofo 125 (1976) 546-551
28. Votta T.J., and Mandel L. Somatoform salivary complaints. N Y S Dent J 68 1 (2002) 22-26